Princeton: Stylish men are perceived as 'significantly more competent'

As much as we say it's not about the clothes, it's still about the clothes.

Princeton: Stylish men are perceived as 'significantly more competent'

David Beckham attends the GQ Men Of The Year Awards 2019 at Tate Modern on September 03, 2019 in London, England.

Photo credit: Mike Marsland / WireImage
  • A new study from Princeton University shows that perception of competence is linked to dress.
  • Researchers discovered the same results over nine separate studies: men that dress better are viewed as more competent.
  • Even when told clothing is not a measure of competence, judges ruled in favor of the better-dressed men.

It would be nice to believe that we judge others not based on how they dress, but on their personal character. While such an idea sounds commendable, it's not true, says a new study out of Princeton University.

Regardless of how much we like to think ourselves above judging based on the clothing others wrap themselves in, such decisions are made much quicker than conscious awareness allows—as little as 130 milliseconds. The paper, which includes research from nine separate studies, confirms the long-held sentiment that "the clothes make the man."

Numerous studies have investigated how we judge faces. Speculation about the role of facial symmetry, large eyes, and prominent cheekbones has been around for decades. For this study — it was published in Nature Human Behavior on Dec. 9 — the researchers flashed the photos of 50 men so quickly that facial recognition proved about impossible. Noticing their torso and, more importantly, what that torso was garbed in, remained possible, however.

The team of DongWon Oh, Eldar Shafir, and Alexander Todorov write,

"Faces were shown with different upper-body clothing rated by independent judges as looking 'richer' or 'poorer', although not notably perceived as such when explicitly described. The same face when seen with 'richer' clothes was judged significantly more competent than with 'poorer' clothes."

Clothing Matters | Jan Erickson | TEDxColoradoSprings

Before beginning, the researchers asked a separate panel of judges to ensure that the clothing they chose was not overtly wealthy or representative of extreme poverty. Those partaking in the study were told to judge the competence of the faces they saw on a scale from one to nine based on "gut feeling."

In a few of the nine studies clothing was explicitly mentioned, though the judges were told to not consider what the people were wearing. In one, they claimed that there was no relationship between clothing and competence.

It didn't matter. In every single study, those rocking finer threads were deemed more competent, even when the same man was shown in different tops. If he was wearing nice clothes, he was deemed more competent than when wearing a t-shirt.

These perceptions influence who we vote for and where we spend our money. Oh believes this is especially important in the age of widespread income inequality.

"Wealth inequality has worsened since the late 1980s in the United States. Now the gap between the top 1 percent and the middle class is over 1,000,000 percent, a mind-numbing figure. Other labs' work has shown people are sensitive to how rich or poor other individuals appear. Our work found that people are susceptible to these cues when judging others on meaningful traits, like competence, and that these cues are hard, if not impossible, to ignore."

The researchers hope that by making people aware of their implicit bias toward clothing, such awareness can later translate into better decision-making about the judgment of an individual's character. As we learn over and over again, fine clothing does not necessary represent an ethical or honest person. It just means they can afford to purchase it.

Rapper Post Malone visits SiriusXM Studio on November 30, 2016 in New York City.

Photo credit: Matthew Eisman/Getty Images

Yet this lesson will be a hard lesson to instill. Clothing has long been representative of social status. Shoes were once a social marker separating those who could afford them compared to those that had to wear sandals or go barefoot. At root, humans are extremely shallow: we'd rather show off what we can afford than help others achieve the same status.

Shafir goes so far to claim that uniformity might be the way to go.

"A potential, even if highly insufficient, interim solution may be to avoid exposure whenever possible. Just like teachers sometimes grade blindly so as to avoid favoring some students, interviewers and employers may want to take what measures they can, when they can, to evaluate people, say, on paper so as to circumvent indefensible yet hard to avoid competency judgments. Academic departments, for example, have long known that hiring without interviews can yield better scholars. It's also an excellent argument for school uniforms."

That will be a hard sell an individualistic culture such as America, where outward appearance too often trumps inner character. As long as that's the case, we have to recognize ourselves for what we are: judgmental creatures focused on exterior presentation. Inner work takes practice, but the benefits — namely, not being conned or focused on fleeting materialism — is worth it.

--

Stay in touch with Derek on Twitter and Facebook. His next book is Hero's Dose: The Case For Psychedelics in Ritual and Therapy.

U.S. Navy controls inventions that claim to change "fabric of reality"

Inventions with revolutionary potential made by a mysterious aerospace engineer for the U.S. Navy come to light.

U.S. Navy ships

Credit: Getty Images
Surprising Science
  • U.S. Navy holds patents for enigmatic inventions by aerospace engineer Dr. Salvatore Pais.
  • Pais came up with technology that can "engineer" reality, devising an ultrafast craft, a fusion reactor, and more.
  • While mostly theoretical at this point, the inventions could transform energy, space, and military sectors.
Keep reading Show less

Why so gassy? Mysterious methane detected on Saturn’s moon

Scientists do not know what is causing the overabundance of the gas.

An impression of NASA's Cassini spacecraft flying through a water plume on the surface of Saturn's moon Enceladus.

Credit: NASA
Surprising Science
  • A new study looked to understand the source of methane on Saturn's moon Enceladus.
  • The scientists used computer models with data from the Cassini spacecraft.
  • The explanation could lie in alien organisms or non-biological processes.
Keep reading Show less

CRISPR therapy cures first genetic disorder inside the body

It marks a breakthrough in using gene editing to treat diseases.

Credit: National Cancer Institute via Unsplash
Technology & Innovation

This article was originally published by our sister site, Freethink.

For the first time, researchers appear to have effectively treated a genetic disorder by directly injecting a CRISPR therapy into patients' bloodstreams — overcoming one of the biggest hurdles to curing diseases with the gene editing technology.

The therapy appears to be astonishingly effective, editing nearly every cell in the liver to stop a disease-causing mutation.

The challenge: CRISPR gives us the ability to correct genetic mutations, and given that such mutations are responsible for more than 6,000 human diseases, the tech has the potential to dramatically improve human health.

One way to use CRISPR to treat diseases is to remove affected cells from a patient, edit out the mutation in the lab, and place the cells back in the body to replicate — that's how one team functionally cured people with the blood disorder sickle cell anemia, editing and then infusing bone marrow cells.

Bone marrow is a special case, though, and many mutations cause disease in organs that are harder to fix.

Another option is to insert the CRISPR system itself into the body so that it can make edits directly in the affected organs (that's only been attempted once, in an ongoing study in which people had a CRISPR therapy injected into their eyes to treat a rare vision disorder).

Injecting a CRISPR therapy right into the bloodstream has been a problem, though, because the therapy has to find the right cells to edit. An inherited mutation will be in the DNA of every cell of your body, but if it only causes disease in the liver, you don't want your therapy being used up in the pancreas or kidneys.

A new CRISPR therapy: Now, researchers from Intellia Therapeutics and Regeneron Pharmaceuticals have demonstrated for the first time that a CRISPR therapy delivered into the bloodstream can travel to desired tissues to make edits.

We can overcome one of the biggest challenges with applying CRISPR clinically.

—JENNIFER DOUDNA

"This is a major milestone for patients," Jennifer Doudna, co-developer of CRISPR, who wasn't involved in the trial, told NPR.

"While these are early data, they show us that we can overcome one of the biggest challenges with applying CRISPR clinically so far, which is being able to deliver it systemically and get it to the right place," she continued.

What they did: During a phase 1 clinical trial, Intellia researchers injected a CRISPR therapy dubbed NTLA-2001 into the bloodstreams of six people with a rare, potentially fatal genetic disorder called transthyretin amyloidosis.

The livers of people with transthyretin amyloidosis produce a destructive protein, and the CRISPR therapy was designed to target the gene that makes the protein and halt its production. After just one injection of NTLA-2001, the three patients given a higher dose saw their levels of the protein drop by 80% to 96%.

A better option: The CRISPR therapy produced only mild adverse effects and did lower the protein levels, but we don't know yet if the effect will be permanent. It'll also be a few months before we know if the therapy can alleviate the symptoms of transthyretin amyloidosis.

This is a wonderful day for the future of gene-editing as a medicine.

—FYODOR URNOV

If everything goes as hoped, though, NTLA-2001 could one day offer a better treatment option for transthyretin amyloidosis than a currently approved medication, patisiran, which only reduces toxic protein levels by 81% and must be injected regularly.

Looking ahead: Even more exciting than NTLA-2001's potential impact on transthyretin amyloidosis, though, is the knowledge that we may be able to use CRISPR injections to treat other genetic disorders that are difficult to target directly, such as heart or brain diseases.

"This is a wonderful day for the future of gene-editing as a medicine," Fyodor Urnov, a UC Berkeley professor of genetics, who wasn't involved in the trial, told NPR. "We as a species are watching this remarkable new show called: our gene-edited future."

Quantcast